share_log

Oppenheimer Upgrades Sensei Biotherapeutics to Outperform, Announces $5 Price Target

Benzinga Real-time News ·  Oct 3, 2022 08:51

Oppenheimer analyst Francois Brisebois upgrades Sensei Biotherapeutics (NASDAQ:SNSE) from Perform to Outperform and announces $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment